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Summary
Chronic obstructive pulmonary disease (COPD) is a common condition in Hong Kong and many affected patients
require frequent admissions to hospital. The indications for hospitalisation for Chinese COPD patients have not been
described for the Hong Kong setting. We have therefore compiled these criteria which artificially divide the admission
process into acute, sub-acute, and elective. Patients should be immediately hospitalised if there is an exacerbation
complicated by severe dyspnoea or respiratory failure. Sub-acute admission is indicated for stabilisation of severe
COPD complications and elective admission is indicated for long term treatment rationalisation. (HK Pract 1998;
20:195-200)
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Definitions and the size of
the problem
Chronic obstructive pulmonary
disease (COPD) is defined as "a
disorder characterized by reduced
maximal expiratory flow and slow
forced emptying of the lungs; features
which do not change over several
months". The airflow limitation due to
vary ing combinat ions of a irway
disease and emphysema, is often
progressive and usually has minimal
"reversibility" with bronchodilator
therapy.' The term COPD describes
the frequently encountered syndrome
of a combination of features of chronic
bronchitis and emphysema, which
almost always co-exist in the same
patient. Chronic bronchitis is defined
as the presence of productive cough for
3 months a year for at least 2 years
with no other identifiable aetiology.
Emphysema is defined pathologically
as irreversible destructive enlargement
of air space distal to the terminal
* Address for correspondence: Dr K W T Tsang, Associate Professor, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pokfulam, Hong
Kong.
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bronchioles wi thou t s ign i f i can t
fibrosis.
Epidemiological studies have
demonstrated an undoubted correlation
between increases in the population's
smoking rate and its development of
disability from COPD some 30 years
later.2,3 This is applicable to the Hong
Kong situation as there was an upsurge
in cigarette smoking back in the 1950s
and 1960s. COPD is a leading cause
of morbidity and mortality in the adult
population world-wide and affects 6%
and 3% of the male and female popula-
tion in the United States respectively.4
COPD also causes s i g n i f i c a n t
morbidity and mortality in Hong Kong.
According to the in-patient statistics in
1994, COPD was the cause of more
than 30,000 admissions into Hospital
A u t h o r i t y (HA) h o s p i t a l s and
constituted more than 3% of all
hospital admissions. Two thirds of
these patients were re-admitted 1 to 5
times within the next 6 months.
The "revolving door" phe-
nomenon
Currently many COPD sufferers
are being frequently re-admitted to
h o s p i t a l s f o r t r e a t m e n t o f
exacerbations. This "revolving door"
phenomenon is characterized by high
admission and re-admission rates.
Intrinsic problems with delivery of the
medica l service, toge ther wi th
inadequate aftercare in part due to poor
home and social support, and poor
patient education have also contributed
to high morbidity and mortality rates in
COPD.
HA has chosen chronic lung
disease to be a priority health target,
aiming to reduce the mortality rate of
COPD patients by 10-15% and their
hospital admission rates by 20% by the
year 2000. Members of the Hong
Kong Thoracic Society, American
College of Chest Physicians (Hong
Kong and Macau Chapter), and HA
consultants have arrived at a consensus
on this issue.
Pathogenic components of
COPD exacerbations
A large number of condi t ions
might lead to acute exacerbations in
COPD, inc lud ing infect ion of the
tracheobronchial tree, pneumonia ,
heart failure, pulmonary embolism,
pneumothorax, inappropriate oxygen
administrat ion, metabolic diseases
s u c h a s d i a b e t e s m e l l i t u s ,
inappropr ia te use of drugs (e.g.
hypnotics, diuretics, t ranquil izers) ,
poor n u t r i t i o n a l s t a t u s , a n d
exace rba t ions of other sys temic
diseases.1 It is beyond the scope of
this article to discuss the pathogenesis,
aetiology, complications, and treatment
of COPD exacerbations. Salient points
have, however, been out l ined in
Table 1.
The need for admission
guidelines
P r a c t i c a l g u i d e l i n e s h a v e
appeared in all medical specialties and
for many common diseases, but some
physicians find them diff icul t to
accept, as many guidelines are rigid
and sometimes non-scient if ical ly
based, particularly as evidence-based
medicine is only a relatively recent
concept. Although COPD is a very
common cause of hospital admission
in Hong Kong and wor ld -wide ,
indica t ions for admission have
received little attention until very
recently.1 , 5 - 7 So far, emergency
admissions have attracted the most
attention. Such evaluation must
include making an accurate diagnosis
through thorough history taking,
physical examination, laboratory and
bed side investigations, with due
reference to the patient's pre-existing
records. The value of admission
guide l ines l ies in their ab i l i ty to
differentiate between the patients who
require in-patient from those who need
only out-patient or emergency room
(ER) care.
Four major English language
guidelines have been published, with
emphasis on different aspects of the
acute and chronic phases of COPD
management. Expert subcommittees
of the American Thoracic,5 Canadian
Thoracic,8 A u s t r a l i a n and New
Zealand Thoracic,9 and the European
Respiratory Societies' have deliberated
in detail on the global management of
patients with COPD, including some
indications for hospitalisation. These
have been modified to suit the Hong
Kong setting as outlined in Table 2.
i
Although the adverse prognostic
and r isk factors in patients with
community-acquired pneumonia such
as hypoxia, multi-lobar involvement,
renal impairment etc., have been firmly
established, similar data on COPD
exacerbations are relatively scarce.10-13
Knowledge of such risk factors is
obviously very important in identifying
patients who suffer from "high risk
exacerbations" and therefore need
early hospitalization. Due to a lack of
local or regional data, the task of
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c o n s t r u c t i n g t h e s e a d m i s s i o n
guidelines was a difficult one, and was
less evidence-based than we desired.
A recent small study performed on
male American patients, so far un-
validated in female patients nor in
Hong Kong, has identified patient
profiles that indicate a need for in-
patient care rather than ER treatment.
These include: previous ER vis i t s
within one week, the number of doses
of nebulised bronchodilators required
in ER, usage of long-term oxygen or
theophylline, and previous relapse
rate.14 Another study concluded
tha t the p r e s e n c e of old age,
PA-aO2>41 mmHg, atrial fibrillation, or
ventricular arrhythmias was associated
with increased morta l i ty in acute
COPD exacerbations.15
As soon as a decision of not
providing in-patient care to a patient
has been made, an acceptable out-
patient management plan must follow.
In addition, it should be emphasised
that many pa t i en t s fal l i l l in a
multifaceted manner, and may also
have de-stabilisation of other pre-
existing or newly developed illnesses
which also require treatment in their
own right (Table 1). The guidelines
must therefore be interpreted flexibly
with due consideration of the severity
of the underlying illness, coexisting
diseases, progression of symptoms,
response to out-patient-based therapy,
and other confounding factors such as
socio-economic considerations.
Component
Tracheobronchial infection
(Usually by viruses, Haemophilus influenzae,
or Streptococcus pneumoniae)
Airflow obstruction
Sputum retention or ineffective coughing
Complications
• Respiratory failure
* Cor pulmonale
* Pneumothorax
» Pneumonia
• Cardiac arrhythmias
• De-stabilization of systemic diseases e.g. diabetes
mellitus, ischaemic heart disease, cerebral vascular disease
* Septicaemia
• Iatrogenic including adverse drug reactions, inappropriate
oxygen therapy, steriod-induced osteoporosis
* Avoid concomitant administration
Acute treatment
Antibiotics (e.g. amoxycillin-clavulanic acid 750 mg t.i.d,;
erythromycin 500 mg q.i.d. etc.)
Bronchodilator (e.g. nebulised salbutamol 5 mg q.i.d. and
ipratropium 500 mcg q.i.d.)
Theophylline (e.g. slow release theophylline 200-300 mg
b.i.d.)
* Oral p2 agonists (e.g. salbutamol 8 mg b.i.d.)
Systemic corticosteroid therapy (e.g. prednisolone 30-
40 mg o.d.)
In-patient physiotherapy
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Interpretat ion of The COPD
Admission Guidelines (Table 2)
Admissions are classified as acute
(immediate), sub-acute (within days)
a n d e l e c t i v e ( w i t h i n w e e k s ) .
Indicat ions for hosp i t a l i sa t ion of
associated pulmonary diseases, e.g.
p n e u m o t h o r a x , p n e u m o n i a a n d
bronchial carcinoma etc., wi l l not be
discussed here. It is impor tan t to
appreciate that these guidelines are by
no means comprehensive, nor is there
any evidence that their application wil l
de f in i t e ly improve the q u a l i t y of
patient care, morbidity, mortality, or
other outcome parameters. Benefits of
having such guidelines could however
inc lude : enhancement of accurate
pa t i en t assessment , r educ t ion of
unnecessary a d m i s s i o n for some
patients, and better deployment of
resources to out -pa t ien t and other
appropriate in-patient services.
After i n i t i a l admiss ion , some
COPD patients fail to stabilise despite
maximal medical and oxygen therapy
and might require h igh dependency
(HDU) or intensive care uni t (1CU)
admission. Whi l s t the Br i t i sh and
A m e r i c a n v i e w s d i f f e r o n t h e
appropriateness of providing intense
treatment to patients who have severe
pre-morbid disease, many such patients
are often treated aggressively in Hong
Kong. It is uncertain whether or not
prolonged treatment of such intensity
for many severely disabled patients
results in favourable outcome in terms
of survival and q u a l i t y of l i fe . A
modified version of the American
Thoracic Society guidelines for HDU/
ICU admission is outlined in Table 3.5
It must be emphasised to the patient,
h is f a m i l y and the c r i t i c a l care
physician that ventilation and other
Table 2: Indications for hospitalisation of COPD patients
Acute admission (immediate)
Acute exacerbation (manifests as increased cough, dyspnoea, sputum production) and
the presence of any of the following:
• Poor response to out-patient therapy
• Significant reduction in exercise tolerance
• Inability to eat or sleep due to dyspnoea
• Repeated choking on eating or drinking due to dyspnoea
• Inability to manage at home and alternative home supporting care not immediately
available
• Significant co-morbid conditions whether respiratory (e.g. pneumothorax) or not
(e.g. unstable diabetes mellitus)
• Respiratory failure (either deterioration of pre-existing or newly developed) - type
I or II
• Mental disturbances such as confusion or disorientation
• Worsening or recent onset cor pulmonale
Sub-acute admission (within days of onset or presentation to out-patient or accident
& emergency departments)
• Poor response to out-patient therapy
• Worsening or recent onset cor pulmonale
• Co-morbid conditions such as steroid-induced myopathy, or acute vertebral
compression fractures or rib fracture which worsen lung function
Elective admission (within weeks of onset or presentation to out-patient or accident
& emergency departments)
• Invasive diagnostic procedures that might worsen lung function or symptoms
• Assessment for long term oxygen therapy
• Early phases of pulmonary rehabilitation
• Need for rationalisation of therapy
Table 3: Indications for HDU/ICU admission in COPD patients who
have satisfactory pre-morbid state
1. Persistent or worsening hypoxaemia despite supplementary oxygen or severe/
worsening respiratory acidosis (pH < 7.30)
2. Confusion, lethargy, or respiratory muscle fatigue
3. Requirement of assisted ventilation (whether invasive or non-invasive)
4. Severe dyspnoea which does not respond or responds poorly to initial emergency
therapy
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1. Chronic obstructive pulmonary disease is a very common condition leading to hospital admission in Hong Kong.
2. Acute and immediate admission should be offered to patients who are in acute exacerbation who have poor response
to out-patient treatment, respiratory failure, mental disturbance, progressive dyspnoea, worsening or new cor pumonale
or inability to cope at home.
3. Sub-acute admission should be offered to out-patients within days of onset of poor response to treatment, cor pulmonale,
or in the presence of a co-morbid condition.
4. Elective admission should be offered to out-patients within weeks for invasive diagnostic procedures, assessment of
home oxygen therapy, rehabilitation, or rationalisation of therapy.
5. The indications for intensive care unit admission for COPD patients are also outlined.
modes of intensive therapy do not cure
or reverse the pre-existing damages in
COPD, and therefore only patients
with satisfactory pre-morbid condition
and significant reversible element(s)
should be offered HDU/ICU therapy.
Prolonged su f fe r ing for both the
patient and his family, erosion of staff
mora l e , and m a l - a l l o c a t i o n of
resources would be the consequences
if this important pr inciple is not
recognised and adhered to.
Conclusions
The obvious long-term strategy to
lower the incidence of COPD is to
reduce smoking through research,
taxation, legislation, education, and
de-marketing.16 Smoking cessation
decreases the degree of lung function
impairment and delays disability and
death in COPD, as well as preventing
the development of other major causes
of mor ta l i ty and morb id i ty , e.g.
bronchial carcinoma, ischaemic heart
disease, and cerebrovascular disease.
In the short and medium terms,
improvement in the outcome of COPD
patients largely depends on the
provision of optimal care in both the
hospital and the community. Long-
term domici l iary oxygen therapy
i m p r o v e s s u r v i v a l , e x e r c i s e
performance, and activities of daily
l iv ing in selected patients,1 7 and is
already widely practised in Hong
Kong. Further strategies have to be
d e v e l o p e d t o w a r d s t he b e t t e r
management of this disease. Issues
such as patient education, coordination
and integration of acute and non-acute
services and in-patient and out-patient
treatment programs of rehabilitation,
establishment of clinical guidelines
and standards of care have all been
considered. The Society and the
College have collated these views
towards future recommendations, and
have decided to publish the current
guidelines regarding hospitalisation of
COPD patients. It is hoped that these
guidelines would help streamline care
as soon as possible after diagnosis and
on presentation of acute symptoms,
whilst perhaps reducing unnecessary
hospitalisation of these patients.
As the ou t l ined c r i t e r ia are
applied and validated, we should study
their impact on the morbidity and
mortality, and identify further risk
factors and information that would
help manage COPD patients. •
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